Randomised study of pessary vs standard management in women with increased chance of premature birth

ISRCTN ISRCTN01096902
DOI https://doi.org/10.1186/ISRCTN01096902
ClinicalTrials.gov number NCT00735137
Secondary identifying numbers 07WH10
Submission date
05/04/2008
Registration date
28/05/2008
Last edited
13/03/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Kypros Nicolaides
Scientific

Harris Birthright Research Centre for Fetal Medicine
King's College Hospital
Denmark Hill
London
SE5 9RS
United Kingdom

Study information

Study designMulti-centre randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typePrevention
Participant information sheet Patient information sheet for women with singleton pregnancies can be found at http://www.fetalmedicine.com/research/prem-single-info.htm. Patient information sheet for women with twin pregnancies can be found at http://www.fetalmedicine.com/research/prem-twins-info.htm.
Scientific titleRandomised study of pessary vs standard management in women with increased chance of premature birth
Study objectivesCurrent hypothesis as of 12/08/2008:
Is pessary useful in reducing risk of premature birth in women with singleton pregnancies with a short cervix (cervical length of 25 mm or less at 21-24 weeks) or in twin pregnancies?

Previous hypothesis:
Is pessary useful in reducing the risk of premature birth in twin pregnancy?
Ethics approval(s)King's College Hospital Research Ethics Committee, 31/01/2008, ref: 08/H0808/3
Health condition(s) or problem(s) studiedPremature birth in women with increased risk of premature birth
InterventionTreatment with insertion of vaginal pessary vs expectant management. The vaginal pessary is inserted in those allocated to this group within 5 days after the 20-24+6 weeks scan. The pessary will be removed by a simple vaginal examination before delivery.
Intervention typeOther
Primary outcome measureSpontaneous delivery before 34 weeks of gestation
Secondary outcome measures1. Birth weight (mean, less than 2.5 kg and less than 1.5 kg)
2. Foetal or neonatal death
3. Major adverse outcomes before discharge from the hospital (intraventricular haemorrhage, respiratory distress syndrome, retinopathy of prematurity or necrotising entercolitis)
4. Need for neonatal special care (admission to a neonatal intensive care unit, ventilation, phototherapy, treatment for proven or suspected sepsis or blood transfusion). Duration of follow-up: 2 years
Overall study start date15/04/2008
Completion date15/04/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants2,780 (1,180 twin pregnancies and 1,600 singleton pregnancies)
Key inclusion criteriaCurrent inclusion criteria as of 12/08/2008:
1. Women with singleton pregnancies and with a cervical length of 25 mm or less
2. Women with twin pregnancies

Previous inclusion criteria:
1. Women with twin pregnancies undergoing routine ultrasonography at 20-24+6 weeks of gestation for examination of foetal anatomy and growth
2. Both foetuses are found to be alive with no major abnormalities, severe twin to twin transfusion syndrome or severe foetal growth restriction
Key exclusion criteriaCurrent exclusion criteria as of 12/08/2008:
1. Major foetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery), foetal death, severe twin to twin transfusion syndrome or severe foetal growth restriction in one of the foetuses (in the case of twin pregnancy) diagnosed before randomisation
2. Painful regular uterine contractions, history of ruptured membranes, or prophylactic cerclage before randomisation
3. Patients who are unconscious, severely ill, mentally handicapped or under the age of 16 years
Previous exclusion criteria:
1. Major foetal abnormalities (defined as those that are lethal or require prenatal or postnatal surgery), or death of one or both of the foetuses, severe twin to twin transfusion syndrome diagnosed before randomisation
2. Painful regular uterine contractions, history of ruptured membranes, or prophylactic cerclage before randomisation
3. Patients who are unconscious, severely ill or mentally handicapped
4. Under the age of 16 years
Date of first enrolment15/04/2008
Date of final enrolment15/04/2012

Locations

Countries of recruitment

  • Brazil
  • Chile
  • Colombia
  • England
  • Portugal
  • Spain
  • United Kingdom

Study participating centre

King's College Hospital
London
SE5 9RS
United Kingdom

Sponsor information

King's College Hospital NHS Foundation Trust (UK)
Hospital/treatment centre

Directorate of Research and Development
King's College Hospital
Denmark Hill
London
SE5 9RS
England
United Kingdom

Website http://www.kch.nhs.uk
ROR logo "ROR" https://ror.org/01n0k5m85

Funders

Funder type

Charity

Fetal Medicine Foundation (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
FMF
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/01/2016 Yes No
Results article results 17/03/2016 Yes No

Editorial Notes

13/03/2020: Internal review.
18/03/2016: Publication reference added.
12/08/2008: This trial record has been extensively amended. The changes include the following:
1. The trial title has been changed from "Randomised study of pessary vs expectant management in twins" to "Randomised study of pessary vs standard management in women with increased chance of premature birth"
2. The information given in the disease/condition/study domain has been changed from "Premature birth in twins pregnancy" to "Premature birth in women with increased risk of premature birth"
3. The target number of participants has been changed from 1,180 to 2,780 (1,180 twin pregnancies and 1,600 singleton pregnancies)
Other changes are recorded in the relevant fields under the date on which the amendments were made.